Author

Max Kurlbaum

Universitätsklinikum WürzburgORCID 0000-0002-8438-2127Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

Barbara AltieriiD· 1 shared Hermann EinseleiD· 1 shared Justus WeberiD· 1 shared Katja Kiseljak‐VassiliadesiD· 1 shared Laura‐Sophie LandwehriD· 1 shared Leon GehrkeiD· 1 shared Marc Philipp SchaueriD· 1 shared Margaret E. WiermaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Barbara AltieriORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Tumour-derived glucocorticoids amplify ROR1 and are exploited with glucocorticoid-resistant ROR1 CAR-T cells

Marc Philipp Schauer, Justus Weber, Peter Spieler, Barbara Altieri, Leon Gehrke, Silviu Sbiera, Stefan Kircher, Max Kurlbaum, Matthias Kroiß, Katja Kiseljak‐Vassiliades, Margaret E. Wierman, Thomas Nerreter, Sophia Danhof, Hermann Einsele, Martin Faßnacht, , Michael Hudecek

The paper shows that tumor-derived glucocorticoids increase ROR1 expression while suppressing T cell activity, and GC-resistant CAR-T cells can overcome this by preserving ROR1 expression in tumor cells.

bioRxiv · Jan 28, 2025 · PreprintCancer Biology